title: [OKT3 for recipients with steroid-resistant acute rejection after liver transplantation].
authors: Organ Transplantation Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. lw97002@163.com
authors: Lin-Wei
authors: LW
authors: Wu
authors: Xiao-Shun
authors: XS
authors: He
authors: Xiao-Feng
authors: XF
authors: Zhu
authors: Dong-Ping
authors: DP
authors: Wang
authors: Wei-Qiang
authors: WQ
authors: Ju
authors: Qiang
authors: Q
authors: Tai
authors: Jie-Fu
authors: JF
authors: Huang
mesh_terms: D000328:Adult; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3